脳モニタリングの世界市場：2024-2031年

脳モニタリング市場は予測期間（2024-2031年）にCAGR 7.8％で成長すると予測されます。脳モニタリング市場は、神経疾患の有病率の上昇、脳イメージング技術の進歩、高齢化などの要因によって大きな成長を遂げています。さらに、非侵襲的診断技術への嗜好とともに、認知度の向上とスクリーニングプログラムが市場の拡大に寄与しています。脳モニタリングシステムにAIや機械学習アルゴリズムを統合することで、診断精度が向上し、リアルタイムの意思決定が可能になります。この市場は、早期診断、個別化された治療計画、病気の進行モニタリングをサポートし、現代のヘルスケア提供や神経学的研究に不可欠な役割を果たしています。技術革新は、ユーザーエクスペリエンスの向上、データ精度の向上、脳モニタリングシステムの機能拡張に重点を置いており、市場の重要性をさらに高めています。

市場力学

脳卒中発症率と死亡率の増加

低・中所得国における脳卒中発症率の増加は、効果的な脳卒中予防対策法の重要性を示しており、迅速な発見とリハビリテーションのための脳モニタリング技術の活用が求められています。世界脳卒中機構（WSO）のランセット神経学委員会報告書によると、各国政府と医療システムは脳卒中予防に関する勧告を実施するよう求められています。同報告書では、脳卒中患者の大幅な増加を予測しており、2050年までに脳卒中による死亡者は年間970万人に達し、その90.0％以上が低・中所得国で発生すると推定しています。高血圧や糖尿病などの要因による若年層や中年層の脳卒中発症の増加は、2050年までに2兆3,000億米ドルの世界の費用予測に寄与しています。さらに、脳卒中に関連した身体障害の有病率は、高所得国に比べてLMICsではより速いペースで増加しています。

診断と治療における技術の進歩

画像診断やモニタリングの技術進歩により、乳がんや神経疾患の発見と治療が大幅に改善されました。ステージIVの乳がん患者の約10.0％～15.0％に脳転移が認められます。脳転移のリスクは通常、HER2陽性乳がんやトリプルネガティブ乳がんなど、より侵攻性の高いサブタイプの乳がんの患者さんで最も高くなります。全米乳がん財団（National Breast Cancer Foundation, Inc.）によると、2024年4月には、浸潤性乳がんの新規症例が310,720例、非浸潤性乳がんの新規症例が56,500例と推定され、乳がんは米国の女性にかなりの影響を及ぼします。しかし、米国では現在400万人以上の乳がんサバイバーがおり、治療とケアの進歩を強調していることは重要です。悲劇的なことに、乳がんは依然として女性の死因のトップであり、2024年には推定42,250人の米国女性がこの病気で命を落とすと予想されています。再発のリスクは、最初の乳がんの種類と病期によって異なり、一般に治療後数年間に最も高いリスクが生じ、時間の経過とともに減少します。

市場セグメンテーション

• タイプ別に見ると、磁気共鳴画像（MRI）スキャナー、コンピュータ断層撮影（CT）スキャナー、脳波計（EEG）デバイス、陽電子放射断層撮影（PET）スキャナー、睡眠モニタリングデバイス、脳オキシメーター、筋電図（EMG）デバイス、頭蓋内圧（ICP）モニター、脳磁図（MEG）デバイス、経頭蓋ドップラー（TCD）デバイスに区分されます。
• 用途別に見ると、市場はパーキンソン病、外傷性脳損傷、てんかん、認知症、睡眠障害、脳卒中、頭痛、その他（ハンチントン病）に区分されます。
• エンドユーザー別では、市場は病院、診断センター、外来手術センター（ASC）・クリニックに区分されます。

脳波計が最大セグメントとなる見通し

このセグメントの成長を支える主な要因には、心血管疾患や併存疾患、脳卒中、その他の心血管疾患に伴う神経学的な疾患の割合が増加しており、通常、広範な脳モニタリングが必要であることが挙げられます。心血管系の合併症を持つ特殊な患者の脳活動と予測を調べるには、脳波（EEG）装置が不可欠です。世界心臓連盟によると、2023年、心血管疾患は世界で5億人以上に影響を及ぼし、2021年には2,050万人の死亡を引き起こします。心血管医学の進歩により、早発心臓発作や脳卒中の最大80.0%を予防できる一方で、CVDによる死亡の5人に4人は低・中所得国で発生しており、その進行は高所得国に集中しているため、最も必要としている地域には恩恵が及ばないことが多いです。

てんかんサブセグメントが大きな市場シェアを占める

神経疾患の有病率が世界的に上昇していることから、正確な診断、発作活動の継続的モニタリング、治療効果の向上を支援する脳モニタリング技術の進歩が求められています。世界保健機関（WHO）によると、2024年2月には、てんかんは世界で5,000万人が罹患する神経疾患であり、発作のない生活を70.0%送ることができますが、特に低所得国では早死のリスクが3倍高くなります。

地域別展望

脳モニタリング市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア太平洋地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）など、地域別にさらに細分化されています。

アジア太平洋地域の農村部における医療インフラ

地域密着型の検診プログラム、遠隔医療プラットフォーム、モバイルヘルスイニシアチブを通じ、農村地域における医療インフラの価値を高めることは、認知症患者が即座にケアを受けられるようにし、早期発見率を高めることにつながります。National Center for Biotechnology Informationによると、2023年7月のインドにおける認知症有病率は7.4％で、60歳以上の成人880万人が認知症を患っており、特に女性と農村部で高いです。

北米が主要市場シェアを占める

脳損傷の有病率の増加により、脳波（EEG）、磁気共鳴画像法（MRI）、コンピュータ断層撮影（CT）スキャンなどの最新のモニタリング技術が、効率的な診断と治療に不可欠となっています。米国生化学分子生物学会によると、2021年3月、米国では9秒に1回の割合で脳損傷が発生しており、年間350万人以上が負傷しています。これらの損傷は、その原因によって非外傷性のものと外傷性のものがあります。米国では年間280万人がTBIを受け、28万人が入院しています。約5万人が死亡しており、毎日155人がTBI関連の怪我で死亡しています。60人に1人がTBIに関連した障害を負っています。

脳モニタリング市場に参入している主な企業は、GE HealthCare Technologies Inc.、Integra LifeSciences Corp.、Medtronic PLC、Koninklijke Philips N.V.、Masimo Corp.などです。市場競争力を維持するため、各社は提携、合併、買収などの戦略を適用し、事業拡大と開発にますます注力しています。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主要市場動向
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• GE HealthCare Technologies Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Integra LifeSciences Corporation
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Medtronic PLC
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 脳モニタリングの世界市場：タイプ別
  • 磁気共鳴画像（MRI）スキャナー
  • コンピューター断層撮影（CT）スキャナー
  • 脳波計（EEG）デバイス
  • 陽電子放射断層撮影（PET）スキャナー
  • 睡眠モニタリングデバイス
  • 脳オキシメーター
  • 筋電図（EMG）デバイス
  • 頭蓋内圧（ICP）モニター
  • 脳磁図（MEG）デバイス
  • 経頭蓋ドップラー（TCD）デバイス
• 脳モニタリングの世界市場：用途別
  • パーキンソン病
  • 外傷性脳損傷
  • てんかん
  • 認知症
  • 睡眠障害
  • 脳卒中
  • 頭痛
  • その他（ハンチントン病）
• 脳モニタリングの世界市場：エンドユーザー別
  • 病院
  • 診断センター
  • 外来手術センター（ASC）・クリニック

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 企業プロファイル

• Advanced Brain Monitoring Inc.
• BrainScope Company Inc.
• Cadwell Industries Inc.
• Compumedics Ltd.
• EB Neuro S.p.A.
• Elekta
• FUJIFILM Holdings Corp.
• Koninklijke Philips N.V.
• Masimo Corp.
• Micromed S.p.A.
• Natus Medical Inc.
• NeuroLogica Corp.
• NeuroPace, Inc.
• Nihon Kohden Corporation
• Rhythmlink International, LLC
• Siemens Healthineers International AG
• Unilabs Holdings AB

LIST OF TABLES

• 1. Global Brain Monitoring Market Research And Analysis By Type, 2023-2031 ($ Million)
• 2. Global Magnetic Resonance Imaging For Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 3. Global Computerized Tomography For Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 4. Global Electroencephalograph For Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 5. Global Positron Emission Tomography For Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 6. Global Sleep Monitoring Devices For Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 7. Global Cerebral Oximeters For Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 8. Global Electromyography For Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 9. Global Intracranial Pressure For Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 10. Global Magnetoencephalography For Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 11. Global Transcranial Doppler For Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 12. Global Other Type Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 13. Global Brain Monitoring Market Research And Analysis By Application 2023-2031 ($ Million)
• 14. Global Brain Monitoring In Parkinson's Disease Market Research And Analysis By Region, 2023-2031 ($ Million)
• 15. Global Brain Monitoring In Traumatic Brain Injury Market Research And Analysis By Region, 2023-2031 ($ Million)
• 16. Global Brain Monitoring In Epilepsy Market Research And Analysis By Region, 2023-2031 ($ Million)
• 17. Global Brain Monitoring In Dementia Market Research And Analysis By Region, 2023-2031 ($ Million)
• 18. Global Brain Monitoring In Sleep Disorders Market Research And Analysis By Region, 2023-2031 ($ Million)
• 19. Global Brain Monitoring In Stroke Market Research And Analysis By Region, 2023-2031 ($ Million)
• 20. Global Brain Monitoring In Headache Disorders Market Research And Analysis By Region, 2023-2031 ($ Million)
• 21. Global Brain Monitoring In Other Application Market Research And Analysis By Region, 2023-2031 ($ Million)
• 22. Global Brain Monitoring Market Research And Analysis By End-User, 2023-2031 ($ Million)
• 23. Global Brain Monitoring For Hospitals Market Research And Analysis By Region, 2023-2031 ($ Million)
• 24. Global Brain Monitoring For Diagnostic Centers Market Research And Analysis By Region, 2023-2031 ($ Million)
• 25. Global Brain Monitoring For Ambulatory Surgery Centers (ASCS) & Clinics Market Research And Analysis By Region, 2023-2031 ($ Million)
• 26. Global Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 27. North American Brain Monitoring Market Research And Analysis By Country, 2023-2031 ($ Million)
• 28. North American Brain Monitoring Market Research And Analysis By Type, 2023-2031 ($ Million)
• 29. North American Brain Monitoring Market Research And Analysis By Application, 2023-2031 ($ Million)
• 30. North American Brain Monitoring Market Research And Analysis By End-User, 2023-2031 ($ Million)
• 31. European Brain Monitoring Market Research And Analysis By Country, 2023-2031 ($ Million)
• 32. European Brain Monitoring Market Research And Analysis By Type, 2023-2031 ($ Million)
• 33. European Brain Monitoring Market Research And Analysis By Application, 2023-2031 ($ Million)
• 34. European Brain Monitoring Market Research And Analysis By End-User, 2023-2031 ($ Million)
• 35. Asia-Pacific Brain Monitoring Market Research And Analysis By Country, 2023-2031 ($ Million)
• 36. Asia-Pacific Brain Monitoring Market Research And Analysis By Type, 2023-2031 ($ Million)
• 37. Asia-Pacific Brain Monitoring Market Research And Analysis By Application, 2023-2031 ($ Million)
• 38. Asia-Pacific Brain Monitoring Market Research And Analysis By End-User, 2023-2031 ($ Million)
• 39. Rest Of The World Brain Monitoring Market Research And Analysis By Region, 2023-2031 ($ Million)
• 40. Rest Of The World Brain Monitoring Market Research And Analysis By Type, 2023-2031 ($ Million)
• 41. Rest Of The World Brain Monitoring Market Research And Analysis By Application,2023-2031 ($ Million)
• 42. Rest Of The World Brain Monitoring Market Research And Analysis By End-User, 2023-2031 ($ Million)

LIST OF FIGURES

• 1. Global Brain Monitoring Market Share By Type, 2023 Vs 2031 (%)
• 2. Global Magnetic Resonance Imaging Brain Monitoring Market Share By Region, 2023 Vs 2031 (%)
• 3. Global Computerized Tomography For Brain Monitoring Market Share By Region, 2023 Vs 2031 (%)
• 4. Global Electroencephalograph For Brain Monitoring Market Share By Region, 2023 Vs 2031 (%)
• 5. Global Positron Emission Tomography For Brain Monitoring Market Share By Region, 2023 Vs 2031 (%)
• 6. Global Sleep Monitoring Devices For Brain Monitoring Market Share By Region, 2023 Vs 2031 (%)
• 7. Global Cerebral Oximeters Brain For Monitoring Market Share By Region, 2023 Vs 2031 (%)
• 8. Global Electromyography Brain For Monitoring Market Share By Region, 2023 Vs 2031 (%)
• 9. Global Intracranial Pressure Brain For Monitoring Market Share By Region, 2023 Vs 2031 (%)
• 10. Global Magnetoencephalography For Brain Monitoring Market Share By Region, 2023 Vs 2031 (%)
• 11. Global Transcranial Doppler For Brain Monitoring Market Share By Region, 2023 Vs 2031 (%)
• 12. Global Brain Monitoring Market Share By Application 2023 Vs 2031 (%)
• 13. Global Brain Monitoring In Parkinson's Disease Market Share By Region, 2023 Vs 2031 (%)
• 14. Global Brain Monitoring In Traumatic Brain Injury Market Share By Region, 2023 Vs 2031 (%)
• 15. Global Brain Monitoring In Epilepsy Market Share By Region, 2023 Vs 2031 (%)
• 16. Global Brain Monitoring In Dementia Market Share By Region, 2023 Vs 2031 (%)
• 17. Global Brain Monitoring In Sleep Disorders Market Share By Region, 2023 Vs 2031 (%)
• 18. Global Brain Monitoring In Stroke Market Share By Region, 2023 Vs 2031 (%)
• 19. Global Brain Monitoring In Headache Disorders Market Share By Region, 2023 Vs 2031 (%)
• 20. Global Brain Monitoring In Other Application Market Share By Region, 2023 Vs 2031 (%)
• 21. Global Brain Monitoring Market Share By End-User, 2023 Vs 2031 (%)
• 22. Global Brain Monitoring For Hospitals Market Share By Region, 2023 Vs 2031 (%)
• 23. Global Brain Monitoring For Diagnostic Centers Market Share By Region, 2023 Vs 2031 (%)
• 24. Global Brain Monitoring For Ambulatory Surgery Centers (ASCS) & Clinics Market Share By Region, 2023 Vs 2031 (%)
• 25. Global Brain Monitoring Market Share By Region, 2023 Vs 2031 (%)
• 26. US Brain Monitoring Market Size, 2023-2031 ($ Million)
• 27. Canada Brain Monitoring Market Size, 2023-2031 ($ Million)
• 28. UK Brain Monitoring Market Size, 2023-2031 ($ Million)
• 29. France Brain Monitoring Market Size, 2023-2031 ($ Million)
• 30. Germany Brain Monitoring Market Size, 2023-2031 ($ Million)
• 31. Italy Brain Monitoring Market Size, 2023-2031 ($ Million)
• 32. Spain Brain Monitoring Market Size, 2023-2031 ($ Million)
• 33. Rest Of Europe Brain Monitoring Market Size, 2023-2031 ($ Million)
• 34. India Brain Monitoring Market Size, 2023-2031 ($ Million)
• 35. China Brain Monitoring Market Size, 2023-2031 ($ Million)
• 36. Japan Brain Monitoring Market Size, 2023-2031 ($ Million)
• 37. South Korea Brain Monitoring Market Size, 2023-2031 ($ Million)
• 38. Rest Of Asia-Pacific Brain Monitoring Market Size, 2023-2031 ($ Million)
• 39. Latin America Brain Monitoring Market Size, 2023-2031 ($ Million)
• 40. Middle East And Africa Brain Monitoring Market Size, 2023-2031 ($ Million)

Brain Monitoring Market Size, Share & Trends Analysis Report by Type (MRI Scanners, CT Scanners, EEG Devices, PET Scanners, Sleep Monitoring Devices, Cerebral Oximeters, EMG Devices, ICP Monitors, MEG Devices, and TCD Devices), by Application (Parkinson's Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders, Stroke, Headache Disorders, and Others), and by End User (Hospitals, Diagnostic Centers, and Ambulatory Surgery Centers (ASCs) & Clinics), Forecast Period (2024-2031)

Brain monitoring market is anticipated to grow at a CAGR of 7.8% during the forecast period (2024-2031). The brain monitoring market is experiencing significant growth, driven by factors such as the rising prevalence of neurological disorders, advancements in brain imaging technologies, and an aging population. Additionally, increasing awareness and screening programs, along with the preference for non-invasive diagnostic techniques, contribute to the market's expansion. The integration of AI and machine learning algorithms in brain monitoring systems improves diagnostic accuracy and enables real-time decision-making. This market plays an essential role in modern healthcare delivery and neurological research, supporting early diagnosis, personalized treatment planning, and disease progression monitoring. Technological innovations focus on enhancing user experience, and data accuracy, and expanding the capabilities of brain monitoring systems, further contributing to the market's significance.

Market Dynamics

Increasing Stroke Incidence and Mortality

The rising incidence of strokes in countries with low and middle incomes indicates the significance of effective stroke preventative measures methods, demanding the utilization of brain monitoring technology for rapid detection and rehabilitation. According to the World Stroke Organization new (WSO) Lancet Neurology Commission report, governments and healthcare systems are being urged to implement stroke prevention recommendations. The report projects a significant increase in stroke cases, estimating that by 2050, strokes will claim 9.7 million lives annually, with over 90.0% of these deaths occurring in low- and middle-income countries. The rise in stroke incidence among young and middle-aged individuals, driven by factors such as hypertension and diabetes, is contributing to a global cost projection of $2.3 trillion by 2050. Additionally, the prevalence of stroke-related disability is increasing at a faster rate in LMICs compared to high-income countries.

Technological Advancements in Diagnosis and Treatment

Technological advancements in diagnostic imaging and monitoring have significantly improved the detection and treatment of breast cancer and neurological disorders. About 10.0% to 15.0% of individuals with stage IV breast cancer have brain metastases. The risk of brain metastasis is usually highest for individuals with more aggressive subtypes of breast cancer, such as HER2-positive or triple-negative breast cancer. According to the National Breast Cancer Foundation, Inc., in April 2024, breast cancer has a considerable influence on women in the US, with an estimated 310,720 new cases of invasive breast cancer and 56,500 new cases of non-invasive breast cancer expected in 2024. However, it is important to note that there are currently over 4 million breast cancer survivors in the US, highlighting the progress in treatment and care. Tragically, breast cancer remains a leading cause of death among women, with an estimated 42,250 US women expected to lose their lives to the disease in 2024. The risk of recurrence varies depending on the type and stage of the initial breast cancer, with the highest risk typically occurring in the first few years after treatment and decreasing over time.

Market Segmentation

• Based on the type, the market is segmented into magnetic resonance imaging (MRI) scanners, computerized tomography (CT) scanners, electroencephalograph (EEG) devices, positron emission tomography (PET) scanners, sleep monitoring devices, cerebral oximeters, electromyography (EMG) devices, intracranial pressure (ICP) monitors, magnetoencephalography (MEG) devices, and transcranial doppler (TCD) devices.
• Based on application, the market is segmented into Parkinson's disease, traumatic brain injury, epilepsy, dementia, sleep disorders, stroke, headache disorders, and others (Huntington's disease).
• Based on end-user, the market is segmented into hospitals, diagnostic centers, and ambulatory surgery centers (ASCs) & clinics.

Electroencephalograph is Projected to Emerge as the Largest Segment

The primary factor supporting the segment's growth includes the growing rate of cardiovascular diseases and comorbid conditions, strokes, and other neurological associated with cardiovascular diseases that usually require extensive brain monitoring. To examine brain activity and forecasting in specialized patients with cardiovascular comorbidities, electroencephalogram (EEG) devices are essential. According to the World Heart Federation, in 2023, cardiovascular diseases affect over half a billion individuals globally, causing 20.5 million deaths in 2021. While advances in cardiovascular medicine can prevent up to 80.0% of premature heart attacks and strokes, they often don't benefit communities most in need, with 4 in 5 CVD deaths in low- and middle-income countries and progress concentrated in high-income countries.

Epilepsy Sub-segment to Hold a Considerable Market Share

The rising prevalence of neurological disorders globally has developed a need for the advancement of brain monitoring technologies, which can aid in precise diagnosis, continuous monitoring of seizure activity, and enhanced treatment efficacy. According to the World Health Organization (WHO), in February 2024, epilepsy, a neurological disease affecting 50 million individuals globally, can lead to 70.0% seizure-free life, but premature death risk is three times higher, especially in low-income countries.

Regional Outlook

The brain monitoring market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Healthcare Infrastructure in Rural Areas in the Asia-Pacific Region

Increasing the value of healthcare infrastructure in rural regions through community-based screening programs, telemedicine platforms, and mobile health initiatives can help dementia patients acquire immediate care and increase the rate of early detection. According to the National Center for Biotechnology Information, in July 2023, dementia prevalence in India was 7.4%, with 8.8 million adults over 60 living with it, notably higher among females and in rural areas.

North America Holds Major Market Share

The increasing prevalence of brain injuries renders modern monitoring technologies, such as electroencephalogram (EEG), magnetic resonance imaging (MRI), and computed tomography (CT) scans, essential for efficient diagnosis and treatment. According to the American Society for Biochemistry and Molecular Biology, in March 2021, brain injuries in the US occur every nine seconds, resulting in over 3.5 million injuries annually. These injuries can be non-traumatic or traumatic, depending on the source. In the US, 2.8 million individuals sustain a TBI annually, with 280,000 hospitalizations. About 50,000 are fatal, with 155 deaths daily from TBI-related injuries. One in every 60 people has a TBI-related disability.

The major companies serving the brain monitoring market are GE HealthCare Technologies Inc., Integra LifeSciences Corp., Medtronic PLC, Koninklijke Philips N.V., and Masimo Corp., among others. The market players are increasingly focusing on business expansion and development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market.

Recent Developments

• In January 2024, Aditxt acquired a portfolio of EEG brain monitoring technologies and devices, formerly owned by Brain Scientific. The acquisition enabled Pearsanta to enter the neurology monitoring market, offering enhanced diagnostics and monitoring for accurate diagnoses and treatment decisions.
• In July 2023, Beacon Biosignals acquired Dreem's research and development business, enabling clinical trial assessments at scale by integrating Dreem's hardware with Beacon's next-generation EEG analytics platform.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Market Trends
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. GE HealthCare Technologies Inc.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Integra LifeSciences Corporation
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Medtronic PLC
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Brain Monitoring Market by Type
  • 4.1.1. Magnetic Resonance Imaging (MRI) Scanners
  • 4.1.2. Computerized Tomography (CT) Scanners
  • 4.1.3. Electroencephalograph (EEG) Devices
  • 4.1.4. Positron Emission Tomography (PET) Scanners
  • 4.1.5. Sleep Monitoring Devices
  • 4.1.6. Cerebral Oximeters
  • 4.1.7. Electromyography (EMG) Devices
  • 4.1.8. Intracranial Pressure (ICP) Monitors
  • 4.1.9. Magnetoencephalography (MEG) Devices
  • 4.1.10. Transcranial Doppler (TCD) Devices
• 4.2. Global Brain Monitoring Market by Application
  • 4.2.1. Parkinson's Disease
  • 4.2.2. Traumatic Brain Injury
  • 4.2.3. Epilepsy
  • 4.2.4. Dementia
  • 4.2.5. Sleep Disorders
  • 4.2.6. Stroke
  • 4.2.7. Headache Disorders
  • 4.2.8. Others (Huntington's Disease)
• 4.3. Global Brain Monitoring Market by End-user
  • 4.3.1. Hospitals
  • 4.3.2. Diagnostic Centers
  • 4.3.3. Ambulatory Surgery Centers (ASCs) & Clinics

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World
  • 5.4.1. Latin America
  • 5.4.2. Middle East and Africa

6. Company Profiles

• 6.1. Advanced Brain Monitoring Inc.
• 6.2. BrainScope Company Inc.
• 6.3. Cadwell Industries Inc.
• 6.4. Compumedics Ltd.
• 6.5. EB Neuro S.p.A.
• 6.6. Elekta
• 6.7. FUJIFILM Holdings Corp.
• 6.8. Koninklijke Philips N.V.
• 6.9. Masimo Corp.
• 6.10. Micromed S.p.A.
• 6.11. Natus Medical Inc.
• 6.12. NeuroLogica Corp.
• 6.13. NeuroPace, Inc.
• 6.14. Nihon Kohden Corporation
• 6.15. Rhythmlink International, LLC
• 6.16. Siemens Healthineers International AG
• 6.17. Unilabs Holdings AB